Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Daiichi Sankyo
Fish and Richardson
Johnson and Johnson
Chinese Patent Office
McKinsey

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 5,935,935

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 5,935,935
Title: Adenoviral vectors for treatment of hemophilia
Abstract:An adenoviral vector including at least one DNA sequence encoding a clotting factor, such as, for example, Factor VIII, or Factor IX. Such vectors may be administered to a host in an amount effective to treat hemophilia in the host. The vectors infect hepatocytes very efficiently, whereby the hepatocytes express the DNA sequence encoding the clotting factor.
Inventor(s): Connelly; Sheila (Gaithersburg, MD), Kaleko; Michael (Rockville, MD), Smith; Theodore (Germantown, MD)
Assignee: Genetic Therapy, Inc. (Gaithersburg, MD)
Application Number:08/484,891
Patent Claims:see list of patent claims

Details for Patent 5,935,935

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Try a Free Trial Genetic Therapy, Inc. (Gaithersburg, MD) 2016-08-10 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Try a Free Trial Genetic Therapy, Inc. (Gaithersburg, MD) 2016-08-10 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Try a Free Trial Genetic Therapy, Inc. (Gaithersburg, MD) 2016-08-10 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Argus Health
Cipla
Farmers Insurance
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.